EPS (Diluted) for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current diluted EPS (TTM) is $-7.27. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$-7.27
YoY change
-21.7%
5Y CAGR
N/A
Peak year (2021)
$28.29
Latest annual
$-7.26
EPS (Diluted) history chart for Moderna (MRNA) from 2016 to 2025
EPS (Diluted) history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $-7.26 | -21.7% | ||
| 2024 | $-9.27 | -24.9% | ||
| 2023 | $-12.34 | -161.4% | ||
| 2022 | $20.10 | -29.0% | ||
| 2021 | $28.29 | -1543.4% | ||
| 2020 | $-1.96 | +26.5% | ||
| 2019 | $-1.55 | +32.5% | ||
| 2018 | $-1.17 | +62.5% | ||
| 2017 | $-0.72 | -81.0% | ||
| 2016 | $-3.79 | — |
EPS (Diluted) values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Moderna (MRNA) most recent annual diluted EPS stands at $-7.26 (2025) – declined 21.7% year-over-year.
Moderna diluted EPS plunged from $28.29 in 2021 to $-7.26 in 2025, a 125.7% drawdown.
$28.29 stands as the all-time-high annual diluted EPS, posted in 2021, against a low of $-12.34 during 2023.
Within Healthcare, Moderna (MRNA) ranks 9th among 8 peers we track. The peer median for diluted EPS is $13.16.
Moderna EPS (Diluted) by Year
Moderna EPS (Diluted) 2025: $-7.26
Moderna diluted EPS in 2025 was $-7.26, declined 21.7% below 2024.
Moderna EPS (Diluted) 2024: $-9.27
Moderna diluted EPS in 2024 was $-9.27, declined 24.9% below 2023.
Moderna EPS (Diluted) 2023: $-12.34
Moderna diluted EPS in 2023 was $-12.34, plunged 161.4% below 2022. This figure represents the lowest annual value in the available history.
Moderna EPS (Diluted) 2022: $20.10
Moderna diluted EPS in 2022 was $20.10, declined 29.0% below 2021.
Moderna EPS (Diluted) 2021: $28.29
Moderna diluted EPS in 2021 was $28.29.
See more financial history for Moderna (MRNA).
Sector peers — EPS (Diluted)
Companies in the same sector as Moderna, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is Moderna's diluted EPS?
- Latest reported diluted EPS for Moderna (MRNA) is $-7.27 (period ending December 31, 2025).
How has Moderna diluted EPS changed year-over-year?
- Moderna (MRNA) diluted EPS changed -21.7% year-over-year on the latest annual filing.
When did Moderna diluted EPS hit its highest annual value?
- Moderna diluted EPS reached its highest annual value of $28.29 in 2021.
What was Moderna diluted EPS in 2024?
- Moderna (MRNA) diluted EPS in 2024 was $-9.27.
What was Moderna diluted EPS in 2025?
- Moderna (MRNA) diluted EPS in 2025 was $-7.26.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.